{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-040603","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.246830+00:00","generated_at":"2026-06-11T23:00:03.016597+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tivic Health prices $1.4M public offering of 33.2M shares at $0.041/share","bullets":["Priced public offering of 33,173,000 shares at $0.041/share; expected gross proceeds ~$1.4M.","Net proceeds ~$1.2M after placement agent fees and expenses; use for working capital and general corporate purposes.","Maxim Group LLC acted as sole placement agent; received 8% cash fee ($108,807) and warrants for 1,326,920 shares at $0.0492.","Offering closed on August 9, 2023; officers and directors entered 30-day lock-up agreements."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-040603","json":"https://secwatch.observer/filing/0000950170-23-040603.json","markdown":"https://secwatch.observer/filing/0000950170-23-040603.md","text":"https://secwatch.observer/filing/0000950170-23-040603.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023040603/0000950170-23-040603-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023040603/tivc-20230806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T23:00:03.016597+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5d46ee49d459e943749971b3ebd69a0cd125c878","claim":"Valion Bio, Inc. entered into Purchase Agreement with the investors named on the signature pages thereto valued at approximately $1.4 million (effective 2023-08-06).","evidence_excerpt":"On August 6, 2023, Tivic Health Systems, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with the investors named on the signature pages thereto (the “Purchasers”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023040603/0000950170-23-040603-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"the investors named on the signature pages thereto"},{"label":"Value","value":"approximately $1.4 million"},{"label":"Effective","value":"2023-08-06"}],"fact_type":"material_agreement"},{"claim_id":"8262e8b40a552e697a20436685bdaff63b6c4cff","claim":"Valion Bio, Inc. entered into Placement Agency Agreement with Maxim Group LLC valued at an aggregate cash fee of 8.0% of the aggregate gross proceeds of the Offering (amounting to $108,807 (effective 2023-08-06).","evidence_excerpt":"On August 6, 2023, the Company and Maxim entered into a Placement Agency Agreement (the “Placement Agency Agreement”), pursuant to which, as compensation for services rendered by the Placement Agent in connection with the Offering, the Company paid the Placement Agent an aggregate cash fee of 8.0% of the aggregate gross proceeds of the Offering (amounting to $108,807) at closing, as well as up to $90,000 for the reimbursement of certain of the Placement Agent’s expenses.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023040603/0000950170-23-040603-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Maxim Group LLC"},{"label":"Value","value":"an aggregate cash fee of 8.0% of the aggregate gross proceeds of the Offering (amounting to $108,807"},{"label":"Effective","value":"2023-08-06"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}